Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TY5K
|
|||
| Former ID |
DIB004460
|
|||
| Drug Name |
NWP-09
|
|||
| Indication | Attention deficit hyperactivity disorder [ICD-11: 6A05.Z; ICD-9: 314] | Phase 3 | [1] | |
| Company |
NextWave Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01654250) NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.